Cannae (CNNE) Reaches New 1-Year High at $22.01

Share on StockTwits

Cannae Holdings Inc (NYSE:CNNE) reached a new 52-week high during trading on Tuesday . The company traded as high as $22.01 and last traded at $22.05, with a volume of 169888 shares. The stock had previously closed at $21.61.

A number of research firms recently commented on CNNE. Zacks Investment Research cut shares of Cannae from a “buy” rating to a “hold” rating in a report on Wednesday, February 6th. Piper Jaffray Companies raised shares of Cannae from a “neutral” rating to an “overweight” rating and set a $25.00 price target on the stock in a report on Friday, November 9th. Finally, ValuEngine cut shares of Cannae from a “strong-buy” rating to a “buy” rating in a report on Monday, February 4th.

The company has a current ratio of 2.12, a quick ratio of 1.75 and a debt-to-equity ratio of 0.01. The firm has a market cap of $1.55 billion, a PE ratio of 14.26 and a beta of 0.73.

In other Cannae news, Director C Malcolm Holland III bought 10,000 shares of the stock in a transaction on Wednesday, November 21st. The shares were acquired at an average price of $17.37 per share, with a total value of $173,700.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 4.90% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. Meeder Asset Management Inc. purchased a new position in shares of Cannae during the 4th quarter valued at $41,000. PNC Financial Services Group Inc. grew its position in shares of Cannae by 13.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,816 shares of the company’s stock valued at $133,000 after purchasing an additional 949 shares in the last quarter. Athena Capital Advisors LLC purchased a new position in shares of Cannae during the 4th quarter valued at $151,000. Raymond James Trust N.A. purchased a new position in shares of Cannae during the 3rd quarter valued at $250,000. Finally, Franklin Resources Inc. purchased a new position in shares of Cannae during the 3rd quarter valued at $255,000. 80.62% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/4164303/cannae-cnne-reaches-new-1-year-high-at-22-01.html.

About Cannae (NYSE:CNNE)

Cannae Holdings, Inc is a principal investment firm. The firm primarily invests in restaurants, technology enabled healthcare services, financial services and more. It takes both minority and majority stakes. Cannae Holdings, Inc is based in Las Vegas, Nevada.

Featured Article: Why do companies issue convertible shares?

Receive News & Ratings for Cannae Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannae and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Advisor Group Inc. Purchases 483 Shares of Sun Life Financial Inc
Advisor Group Inc. Purchases 483 Shares of Sun Life Financial Inc
Critical Contrast: Kingstone Companies  and Selective Insurance Group
Critical Contrast: Kingstone Companies and Selective Insurance Group
Head to Head Survey: RISE Education Cayman  vs. Creative Learning
Head to Head Survey: RISE Education Cayman vs. Creative Learning
683 Capital Management LLC Takes $1.59 Million Position in Brighthouse Financial Inc
683 Capital Management LLC Takes $1.59 Million Position in Brighthouse Financial Inc
10 15 Associates Inc. Reduces Position in Metlife Inc
10 15 Associates Inc. Reduces Position in Metlife Inc
683 Capital Management LLC Acquires 549,000 Shares of Strongbridge Biopharma plc
683 Capital Management LLC Acquires 549,000 Shares of Strongbridge Biopharma plc


© 2006-2019 Ticker Report